EPINEPHRINE
| Brand name | NEFFY |
|---|---|
| Active ingredient | EPINEPHRINE |
| Strength | 2MG/SPRAY |
| Dosage form | SPRAY |
| Route | NASAL |
| Modality | Small molecule |
| FDA approval | August 2024 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12324838 | February 2039 | product |
| 11918655 | February 2039 | product |
| 11717571 | February 2039 | use U-3979 |
| 11191838 | February 2039 | product |
| 11744895 | February 2039 | use U-3979 |
| 10682414 | February 2039 | use U-3979 |
| 10576156 | February 2038 | product |
| 11173209 | February 2038 | use U-3979 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.